your badges 52W Range $5–$26 8% of range Analyst Rating STRONG BUY 15 analysts Price Target $36 +439% upside P/E -2.8 ROE -28.2% Net Profit Margin -912.3%

BIOA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $6.61
Market Cap (MRQ) $303M
P/E (TTM) -2.8
EPS (TTM) $-2.38
Revenue (TTM) $10M
ROE (TTM) -28.2%
Debt/Equity (MRQ) 0.0
52W Range $5–$26

BIOA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$9M
2024-12-31 → 2025-12-31
EPS$-2.24
2023-12-31 → 2025-12-31
Free Cash Flow$-82M
2024-12-31 → 2025-12-31
Net margin-912.3%
2025-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend BIOA 5Y avg Peer Median Verdict
P/E (TTM) -2.8 · · ·
P/S (TTM) 29.2 · 108.4 Fair value
P/B (MRQ) 0.8 · 3.3 Fair value
EV / EBITDA -0.2 · · ·
Price / FCF (TTM) -3.4 · · ·
Price / Cash Flow (TTM) -3.5 · · ·
EV / Revenue (TTM) -1.6 · · ·
EV / FCF (TTM) 0.2 · · ·
Price / Tangible Book 1.1 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 8.0%
Next Report Nov 04, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 12, 2026 $-0.58 $-0.62 7.1%
March 31, 2026 May 12, 2026 $-0.52 $-0.65 20.3%
Dec. 31, 2025 $-0.72 $-0.75 4.5%
Sept. 30, 2025 $-0.56 $-0.60 6.0%
June 30, 2025 $-0.60 $-0.49 -22.3%
March 31, 2025 $-0.36 $-0.54 33.2%
Dec. 31, 2024 $-1.97 $-2.12 7.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 14
Metric Trend 20252024
Revenue $9M$0
R&D Expense $74M$59M
SG&A Expense $28M$19M
Operating Expenses $102M$78M
Operating Income $-93M$-78M
Other Non-op $12M$7M
Pretax Income $-81M$-71M
Income Tax $0$0
Net Income $-81M$-71M
EPS (Basic) $-2.24$-6.63
EPS (Diluted) $-2.24$-6.63
Shares (Basic) 35,932,91410,726,521
Shares (Diluted) 35,932,91410,726,521
EBITDA $-93M$-78M
Balance Sheet 23
Metric Trend 20252024
Cash & Equivalents $189M$354M
Short-term Investments $92M$0
Receivables $769.0K$0
Prepaid Expense $5M$3M
Current Assets $287M$357M
PP&E (Net) $963.0K$591.0K
PP&E (Gross) $1M$962.0K
Accum. Depreciation $482.0K$371.0K
Other Non-current Assets $216.0K$240.0K
Total Assets $295M$358M
Accounts Payable $3M$2M
Current Liabilities $20M$28M
Capital Leases $2M$0
Total Liabilities $23M$35M
Long-term Debt $3M$9M
Total Debt $3M$9M
Common Stock $0$0
Paid-in Capital $605M$576M
Retained Earnings $-333M$-253M
AOCI $278.0K$245.0K
Stockholders' Equity $272M$323M
Liabilities + Equity $295M$358M
Shares Outstanding 37,386,90835,850,037
Cash Flow 10
Metric Trend 20252024
Stock-based Comp $12M$7M
Operating Cash Flow $-82M$-52M
CapEx $719.0K$366.0K
Investing Cash Flow $-95M$-366.0K
Stock Issued $17M$0
Net Stock Activity $17M·
Financing Cash Flow $11M$381M
Net Change in Cash $-165M$329M
Taxes Paid $0$0
Free Cash Flow $-82M$-52M
Profitability 7
Metric Trend 20252024
Operating Margin -1031.5%·
Net Margin -896.1%·
Pretax Margin -896.1%·
EBITDA Margin -1031.5%·
ROA -24.7%-37.0%
ROE -28.4%-22.3%
ROIC -33.8%-23.6%
Liquidity & Solvency 4
Metric Trend 20252024
Current Ratio 14.212.9
Quick Ratio 14.012.8
Debt / Equity 0.00.0
LT Debt / Equity 0.00.0
Efficiency 2
Metric Trend 20252024
Asset Turnover 0.0·
Receivables Turnover 23.4·
Per Share 5
Metric Trend 20252024
Book Value / Share $7.28$9.01
Revenue / Share $0.25·
Cash Flow / Share $-2.27$-4.80
Cash / Share $5.05$9.88
EPS (TTM) $-2.24$-6.63
Valuation (TTM) 14
Metric Trend 20252024
Revenue TTM $9M$0
Net Income TTM $-81M$-71M
Market Cap $495M$208M
Enterprise Value $216M$-138M
P/E -5.9-0.9
P/S 55.0·
P/B 1.80.6
P / Tangible Book 1.80.6
P / Cash Flow -6.1-4.0
P / FCF -6.0-4.0
EV / EBITDA -2.31.8
EV / FCF -2.62.7
EV / Revenue 24.0·
Earnings Yield -16.9%-114.5%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-31
Revenue $9M $0 ·
Operating Margin % -1031.5% · ·
Net Income $-81M $-71M $-64M
Diluted EPS $-2.24 $-6.63 $-38.17

Institutional owners (13F) 166 filers · $946.7M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 166
Value held $946.7M
New positions 36
Exited positions 19
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
36 (-17 vs prior Q) 19 (+3 vs prior Q) 62 (+16 vs prior Q) 39 (+14 vs prior Q) +2.4M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
a16z Capital Management, L.L.C. $79,244,997 3,233,170 8.37% Shares
BlackRock, Inc. $69,830,877 2,849,077 7.38% Shares
Cormorant Asset Management, LP $58,593,729 2,390,605 6.19% Shares
Sofinnova Investments, Inc. $56,220,744 2,293,788 5.94% Shares
Octagon Capital Advisors LP $42,843,480 1,748,000 4.53% Shares
RA CAPITAL MANAGEMENT, L.P. $40,972,092 1,671,648 4.33% Shares
MPM BIOIMPACT LLC $40,874,371 1,667,661 4.32% Shares
VANGUARD CAPITAL MANAGEMENT LLC $37,848,685 1,544,214 4.00% Shares
JANUS HENDERSON GROUP PLC $36,597,368 2,094,270 3.87% Shares
Polar Capital Holdings Plc $26,283,151 1,072,344 2.78% Shares
BRAIDWELL LP $25,321,992 1,033,129 2.67% Shares
STATE STREET CORP $25,036,083 1,021,464 2.64% Shares
GEODE CAPITAL MANAGEMENT, LLC $24,619,235 1,004,264 2.60% Shares
Sands Capital Alternatives, LLC $19,273,512 786,353 2.04% Shares
VANGUARD GROUP INC $18,717,407 1,414,770 1.98% Shares
ORBIMED ADVISORS LLC $18,435,270 752,153 1.95% Shares
D. E. Shaw & Co., Inc. $18,205,072 742,761 1.92% Shares
Balyasny Asset Management L.P. $17,227,050 702,858 1.82% Shares
Pivotal bioVenture Partners Investment Advisor LLC $16,014,197 653,374 1.69% Shares
COSMIC MANAGEMENT, LLC $12,299,927 501,833 1.30% Shares
STEMPOINT CAPITAL LP $11,376,831 464,171 1.20% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $10,053,144 410,165 1.06% Shares
DIMENSIONAL FUND ADVISORS LP $9,661,958 394,138 1.02% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $9,242,353 377,085 0.98% Shares
Walleye Capital LLC $8,686,221 354,395 0.92% Shares
Nuveen, LLC $8,557,471 349,142 0.90% Shares
NORTHERN TRUST CORP $8,410,999 343,166 0.89% Shares
Integral Health Asset Management, LLC $7,353,000 300,000 0.78% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $7,353,000 300,000 0.78% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $7,267,215 296,500 0.77% Call option
MORGAN STANLEY $6,921,282 282,386 0.73% Shares
FRANKLIN RESOURCES INC $6,911,011 281,967 0.73% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $6,700,323 273,371 0.71% Shares
Comprehensive Financial Management LLC $6,662,847 271,842 0.70% Shares
GOLDMAN SACHS GROUP INC $6,636,548 270,769 0.70% Shares
BANK OF AMERICA CORP /DE/ $6,320,026 257,855 0.67% Shares
Squadron Capital Management LLC $6,127,500 250,000 0.65% Call option
JPMORGAN CHASE & CO $5,837,776 233,979 0.62% Shares
MILLENNIUM MANAGEMENT LLC $5,456,441 222,621 0.58% Shares
VANGUARD FIDUCIARY TRUST CO $5,382,396 219,600 0.57% Shares
SPHERA FUNDS MANAGEMENT LTD. $5,237,076 213,671 0.55% Shares
DIADEMA PARTNERS LP $4,904,451 200,100 0.52% Call option
Ikarian Capital, LLC $4,901,999 200,000 0.52% Shares
FMR LLC $4,499,129 183,563 0.48% Shares
Yiheng Capital Management, L.P. $4,179,739 170,532 0.44% Shares
RENAISSANCE TECHNOLOGIES LLC $4,061,307 165,700 0.43% Shares
Squadron Capital Management LLC $3,799,050 155,000 0.40% Shares
DIADEMA PARTNERS LP $3,586,646 146,334 0.38% Shares
Ensign Peak Advisors, Inc $3,473,018 141,698 0.37% Shares
Invesco Ltd. $3,123,064 127,420 0.33% Shares

Show all 166 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
AH Bio Fund I, L.P., AH Equity Partners Bio I, L.L.C., AH Bio Fund III, L.P., AH Equity Partners Bio III, L.L.C., AH Bio Fund IV, L.P., AH Equity Partners Bio IV, L.L.C., Andreessen Horowitz LSV Fund III, L.P., AH Equity Partners LSV III, L.L.C., Marc Andreessen, Benjamin Horowitz Oct. 4, 2024 · Initial filing Passive investment SEC
Sofinnova Venture Partners XI, L.P. (“SVP XI”), Sofinnova Management XI, L.P. (“SM XI LP”), Sofinnova Management XI, L.L.C. (“SM XI LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) Sept. 30, 2024 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 11 insiders · 5 officers · 8 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Kristen Fortney Chief Executive Officer Feb. 17, 2026 A 976,949 0 1 $-4,223,899
GOLDSTEIN DOV A MD Chief Financial Officer April 23, 2026 M 36,575 0 4 $-531,844
Eric Morgen Chief Operating Officer Feb. 17, 2026 A · 0 0 $0
Shane Barton Principal Accounting Officer June 30, 2026 M 0 0 2 $-1,576,885
Paul D Rubin Chief Medical Officer April 1, 2026 M 0 0 6 $-1,460,917
Vijay Satyanand Pande Director June 10, 2026 A 1,119,195 0 0 $0
Rekha Hemrajani Director June 10, 2026 A 3,000 0 0 $0
Michael H. Davidson Director June 10, 2026 A · 0 0 $0
Patrick G. Enright Director June 10, 2026 A 1,710,589 0 0 $0
Dr. James I. Healy Director June 10, 2026 A 26,497 0 0 $0
Jean Pierre Garnier Director June 10, 2026 A · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 27 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
PILL · Direxion Shares ETF Trust 0.41% 9,418 NS July 31, 2026 N-PORT
BBC · ETFis Series Trust I 0.34% 17,229 NS July 31, 2026 N-PORT
DWAS · Invesco Exchange-Traded Fund Trust … 0.17% 99,493 SH Oct. 1, 2026 Daily
VFMO · VANGUARD WELLINGTON FUND 0.16% 127,778 SH Aug. 19, 2026 Daily
IWC · iShares Trust 0.07% 119,410 SH Sept. 11, 2026 Daily
IHE · iShares Trust 0.06% 117,813 SH Sept. 11, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.05% 27,617 SH Aug. 19, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.03% 202,410 SH Aug. 19, 2026 Daily
IBBQ · Invesco Exchange-Traded Fund Trust … 0.02% 3,312 SH Oct. 1, 2026 Daily
IBB · iShares Trust 0.02% 238,087 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.01% 16,798 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.01% 367,869 SH Aug. 19, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.01% 3,710 SH Aug. 19, 2026 Daily
IWM · iShares Trust 0.01% 898,857 SH Sept. 11, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 24,712 SH Sept. 30, 2026 Daily
DFAS · Dimensional ETF Trust 0.01% 108,834 NS July 31, 2026 N-PORT
IWO · iShares Trust 0.00% 32,363 SH Sept. 11, 2026 Daily
DCOR · Dimensional ETF Trust 0.00% 4,261 NS July 31, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.00% 642 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 27,726 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.00% 45,801 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 9,051 SH Sept. 3, 2026 Daily
DFAU · Dimensional ETF Trust 0.00% 4,358 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 6,748 NS July 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 1,140,593 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 2,774 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 294,993 SH Sept. 11, 2026 Daily

BIOA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 15 analysts BUY
Median target $30.00 +353.9%
6 40.0% Strong Buy
6 40.0% Buy
3 20.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

8 analysts · 2026-09-28

Mean target $35.62 +439.0%

← Below all targets Current price $6.61
Low$20.00 Mean$35.62 High$73.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
BIOA $495M -5.9 · -896.1% -28.4% ·
TTRX $116M -32.8 · · -141.7% ·
FULC $753M -9.6 2752.0% · -26.6% ·
EYPT $1.51B -5.8 -27.5% -739.4% -84.0% ·
LLY · 46.8 44.7% 31.7% 101.2% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 5, 2026